[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361485-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361485-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrative-pan-cancer-characterization-of-lncrna-upk1a-as1-and-its-role-in-hypoxia-associated-sorafenib-resistance-in-hepatocellular-carcinoma","Integrative Pan-Cancer Characterization of lncRNA UPK1A-AS1 and Its Role in Hypoxia-Associated Sorafenib Resistance in Hepatocellular Carcinoma","","Long noncoding RNAs (lncRNAs) act as regulators of tumor initiation and progression through transcriptional and posttranscriptional mechanisms. This study integrates TCGA, GTEx, CIDE, and cBioPortal to map UPK1A-AS1 across human malignancies, defining its expression, genomic alterations, clinical relevance, and immune links. UPK1A-AS1 is upregulated in multiple tumor types, driven mainly by copy-number amplification. Higher levels associate with advanced stage, poor differentiation, immune exclusion, and worse prognosis. Hypoxia induces UPK1A-AS1 in hepatocellular carcinoma, promoting sorafenib resistance by suppressing apoptosis, while silencing restores apoptotic activity and improves sorafenib efficacy in vitro and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrative-pan-cancer-characterization-of-lncrna-upk1a-as1-and-its-role-in-hypoxia-associated-sorafenib-resistance-in-hepatocellular-carcinoma/361485/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrative-pan-cancer-characterization-of-lncrna-upk1a-as1-and-its-role-in-hypoxia-associated-sorafenib-resistance-in-hepatocellular-carcinoma/361485.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What datasets and resources were integrated to characterize UPK1A-AS1?","Question",{"text":63,"@type":64},"The study integrated datasets from The Cancer Genome Atlas (TCGA), GTEx, the cancer immunology data engine (CIDE), and cBioPortal for cancer genomics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What genomic mechanism mainly drives UPK1A-AS1 overexpression?",{"text":68,"@type":64},"Copy-number amplification is reported as the predominant genomic alteration driving UPK1A-AS1 overexpression.",{"name":70,"@type":61,"acceptedAnswer":71},"How does hypoxia affect UPK1A-AS1 and sorafenib resistance in hepatocellular carcinoma?",{"text":72,"@type":64},"Hypoxia transcriptionally induces UPK1A-AS1, which promotes sorafenib resistance by suppressing apoptosis; silencing UPK1A-AS1 restores apoptosis and enhances sorafenib efficacy in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361485,1790203186,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Analytical Cellular Pathology  \nRESEARCH ARTICLE OPEN ACCESS   \nIntegrative Pan-Cancer Characterization of lncRNA UPK1A-AS1 and Its Role in Hypoxia-Associated Sorafenib Resistance in Hepatocellular Carcinoma  \nZe-Kai Li1  | Min-Rui Luo1  | Shu-Jie Fang1  | Yi-Da Wu1  | Quan-Hui Hu2  | Dong-Yan Zhang1   \n1Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China | 2Department of Health  \nManagement, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China Correspondence: Dong-Yan Zhang ([15013091401@163.com](15013091401@163.com))  \nReceived: 6 May 2026 | Revised: 3 August 2026 | Accepted: 11 August 2026  \nAcademic Editor: Consuelo Amantini  \nKeywords: hepatocellular carcinoma | hypoxia | long noncoding RNA | pan-cancer analysis | sorafenib resistance | UPK1A-AS1  \nABSTRACT  \nLong noncoding RNAs (lncRNAs) are emerging as critical regulators of tumor initiation and progression through transcriptional and posttranscriptional mechanisms. UPK1A antisense RNA 1 (UPK1A-AS1), a cancer-associated lncRNA, has been reported to participate in oncogenic processes; however, its overall landscape across human malignancies and its biological role in therapy resistance remain poorly understood. Given the increasing importance of identifying functional lncRNAs with prognostic and therapeutic potential, this study presents a comprehensive multiomics characterization of UPK1A-AS1 and its experimental validation in hepatocellular carcinoma (HCC) . We integrated datasets from The Cancer Genome Atlas (TCGA), the GenotypeTissue Expression Project (GTEx), the cancer immunology data engine (CIDE), and the cBioPortal for cancer genomics (cBioPortal) to systematically assess its expression pattern, genomic alterations, clinical signiﬁcance, and immunological associations. Our analyses revealed that UPK1A-AS1 is signiﬁcantly upregulated in multiple tumor types, with copy-number ampliﬁcation asthe predominant genomic alteration driving its overexpression. Elevated UPK1A-AS1 expression was correlated with advanced disease stage, poor differentiation, immune exclusion, and unfavorable prognosis, supporting its potential as a cancer typedependent biomarker. In parallel, functional studies demonstrated that hypoxia transcriptionally induces UPK1A-AS1 in HCC, where it promotes sorafenib resistance by suppressing apoptosis. Silencing UPK1A-AS1 restored apoptotic and enhanced sorafenib efﬁcacy both in vitro and in vivo. Collectively, our ﬁndings suggest that UPK1A-AS1 is a hypoxia-inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type-dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia-associated drug resistance in HCC.  \n1 | Introduction  \nCancer remains one of the leading causes of morbidity and mortality worldwide and imposes a substantial public health burden. For numerous cancer types, particularly at the advanced stages, survival outcomes are still unsatisfactory. Global cancer statistics  \nindicate that the incidence and mortality of many malignancies remain high despite advances in prevention, early detection, and systemic therapies [1] . These challenges highlight the urgent need to clarify the molecular mechanisms underlying tumor  \n\n| Ze-Kai Li and Min-Rui Luo contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>Copyright © 2026 Ze-Kai Li et al. Analytical Cellular Pathology published by John Wiley & Sons Ltd. |\n\nAnalytical Cellular Pathology, 2026; 2026:1554526 1 of 26  \n[https://doi.org/10.1155/ancp/1554526](https://doi.org/10.1155/ancp/1554526)  \ninitiation and progression and to identify reliable biomarkers and therapeutic targets to improve cancer management.  \nLong ","cbCain9UpXbTscVb","https://ap.wps.com/l/cbCain9UpXbTscVb","pdf",39844395,26,"English","# Introduction\n## Long noncoding RNAs and cancer relevance\n## UPK1A-AS1 prior evidence in multiple cancers","[{\"question\":\"What datasets and resources were integrated to characterize UPK1A-AS1?\",\"answer\":\"The study integrated datasets from The Cancer Genome Atlas (TCGA), GTEx, the cancer immunology data engine (CIDE), and cBioPortal for cancer genomics.\"},{\"question\":\"What genomic mechanism mainly drives UPK1A-AS1 overexpression?\",\"answer\":\"Copy-number amplification is reported as the predominant genomic alteration driving UPK1A-AS1 overexpression.\"},{\"question\":\"How does hypoxia affect UPK1A-AS1 and sorafenib resistance in hepatocellular carcinoma?\",\"answer\":\"Hypoxia transcriptionally induces UPK1A-AS1, which promotes sorafenib resistance by suppressing apoptosis; silencing UPK1A-AS1 restores apoptosis and enhances sorafenib efficacy in vitro and in vivo.\"}]","Integrative Pan-Cancer Characterization of lncRNA UPK1A-AS1 and Its Role in Hypoxia-Associated Sorafenib Resistance in Hepatocellular Carcinoma | PDF",1790144519,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3d81ab64d51d01f6e4f14bd68ff04da.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/942f85ee40c09faf5894fdb554b46726.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2bafebdeb4a8dbbeaaa10c4e8bb7cc8.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/642bf8fcdd8a43ea1ffccaf30b6bd48b.webp",980,1287]